As of April 1, 2017, the IRCC introduces a new reimbursement scheme for health assessment of Canada-bound refugees as a part of Interim Federal Health Program (IFHP), which until now has been providing temporary coverage of health care benefits to refugees in Canada.

At the request of the Government of the United Kingdom, IOM implements the Tuberculosis (TB) Detection Programme for visa applicants who intend to stay in the UK for a period of 6 months or longer. The main purpose of the programme is to address public health concerns regarding the spread of infectious tuberculosis in the UK by preventing the entry of people suffering from active TB until they have been successfully treated, as well as to facilitate access to diagnostics and referrals for treatment in the migrants’ countries of origin.

IOM will conduct health assessments and treatment services for government-funded migrants going to Australia. The pre-departure health screening services will be based on the new protocol the purpose of which is to reduce the post-arrival medical issues that are presented by Refugee and humanitarian visa holders and to ensure better follow up and treatment on-shore of health problems that have been identified at the point of departure. The project will start in Kigoma and Tanzania, and will expand to other countries in East and West Africa, Middle East and South-East Asia in 2006.

At the request of the Government of Canada, IOM carries out migration health assessment and DNA sample collection services for immigration self-payer applicants referred by the local Canadian High Commissions, in accordance with the Canadian government’s instructions for medical and radiological examination of Canadian visa applicants.

At the request of the Government of Australia, IOM carries out migration health assessment and DNA sample collection services for immigration self-payer applicants referred by local Australian High Commissions, in accordance with the Australian government’s instructions for the medical and radiological examination of Australian visa applicants.

At the request of the Government of the United States of America, IOM carries out migration health assessment, vaccination and DNA sample collection services to self-payer visa applicants referred by local US Embassies, in accordance with the US government’s technical instructions.

At the request of governments and entities other than the Governments of Australia, Canada, New Zealand, United Kingdom and United States, IOM carries out migration health assessment, DNA sample collection, age assessment, and pre-departure medical assessment services for refugees, returnees, students and immigration self-payer applicants referred by various governments and entities, such as UNHCR.

At the request of the Government of New Zealand, IOM is carrying out migration health assessment and DNA sample collection services for immigration self-payer applicants referred by the local New Zealand High Commissions.

The goals of this project are to guarantee, through appropriate medical screening planning, monitoring and support, that a number of eligible refugees consistent with the annual admission quota undergo the medical examination process within the duly timeframe. The project also aims to improve the quality of the medical clearance process through analysis, processing and dissemination of data included in OF 157 forms, enhanced follow-up of medical cases, reduced prevalence of untreated malaria and intestinal parasitosis.

The project refers to the health assessment of Australian-bound movements of visa classes 200 to 204.